Pure Global

Coronary Collaterals and Post-reperfusion Intramyocardial Hemorrhage - Trial NCT05898425

Access comprehensive clinical trial information for NCT05898425 through Pure Global AI's free database. This phase not specified trial is sponsored by Rohan Dharmakumar and is currently Recruiting. The study focuses on Acute Myocardial Infarction. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05898425
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05898425
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Coronary Collaterals and Post-reperfusion Intramyocardial Hemorrhage
Impact of Coronary Collaterals on Post-reperfusion Intramyocardial Hemorrhage in AMI Patients

Study Focus

Observational

Sponsor & Location

Rohan Dharmakumar

Indiana University

Indianapolis, United States of America

Timeline & Enrollment

N/A

Aug 01, 2021

Jul 30, 2023

200 participants

Primary Outcome

Incidence of Intramyocardial hemorrhage (IMH),Volume of Intramyocardial hemorrhage (IMH)

Summary

This study examines the relationship between angiographic coronary collateral grades (Rentrop
 grades) during acute myocardial infarction and post-reperfusion intramyocardial hemorrhage
 volume by cardiac magnetic resonance. This study aims to assess the impact of coronary
 collateral circulation on intramyocardial hemorrhage incidence and extent.

ICD-10 Classifications

Acute myocardial infarction
Acute myocardial infarction, unspecified
Acute subendocardial myocardial infarction
Certain current complications following acute myocardial infarction
Other current complications following acute myocardial infarction

Data Source

ClinicalTrials.gov

NCT05898425

Non-Device Trial